Prevalence of toxoplasmosis, HIV, syphilis and rubella in a population of puerperal women using Whatman 903® filter paper

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 1, 2010, Pages 24-29

  Madi, José Mauro ^a   de Souza, Ricardo da Silva ^a   de Araújo, Breno Fauth ^a   Filho, Petrônio Fagundes de Oliveira ^a   Rombaldi, Renato Luís ^a   Mitchell, Charles ^b   Lorencetti, Jucemara ^a   Marcon, Nathalia Oliva ^a  

^a UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical diagnosis; Congenital infections; Perinatal infections; Seroprevalence

Indexed keywords

ALCOHOL; COCAINE;

ADULT; ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HEALTH CARE NEED; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN INTENSIVE CARE; NONHUMAN; PERINATAL INFECTION; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PREVALENCE; PUERPERIUM; RUBELLA; SEROPREVALENCE; SYPHILIS; TEST STRIP; TOXOPLASMOSIS;

EID: 77954779451     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1413-8670(10)70006-4     Document Type: Article

References (25)

1. Wendel PJ, Wendel GD, Jr. Sexually transmitted diseases in pregnancy. Sem Perinatol 1993; 17(6):443-51.
2. Forrest JM, Turnbull FM, Sholler GF et al. Gregg's congenital rubella patients 60 years later. Med J Australia 2002; 177(11-12):664-7.
3. Lorenzi DRS, Madi JM. Sífilis congênita como indicador de assistência pré-natal. Rev Bras Ginecol Obstet 2001; 23(10):647-52.
4. Ramos Jr AN, Matida LH, Saraceni V et al. Control of motherto-child transmission of infectious diseases in Brazil: progress in HIV/AIDS and failure in congenital syphilis. Cad Saude Pub 2007; 23Suppl3:S370-8.
5. Fontes M, Hillis J, Wasek G. Children affected by AIDS in Brazil: estimates of the number of children at risk of being orphaned and displaced by AIDS in Brazil. Childhood 1998; 5(3):345-63.
6. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. NEJM 1994; 331(18):1173-80.
7. Goldani MZ, Giugliani ER, Scanlon T et al. Voluntary HIV counseling and testing during prenatal care in Brazil. Rev Saude Pub 2003; 37(5):552-8.
8. Elsheikha HM. Congenital toxoplasmosis: priorities for further health promotion action. Public Health 2008; 122(4):335-53.
9. De Paschale M, Agrappi C, Clerici P et al. Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy. Clin Microbiol Infect 2008; 14(2):186-9.
10. Kimball AC, Kean BH, Fuchs F. Congenital toxoplasmosis: a prospective study of 4,048 obstetric patients. Am J Obstet Gynecol 1971; 111(2):211-8.
11. Ferguson W, Mayne PD, Lennon B et al. Susceptibility of pregnant women to toxoplasma infection:--potential benefits for newborn screening. Irish Med J 2008; 101(7):220-1.
12. Jones JL, Kruszon-Moran D, Wilson M et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154(4):357-65.
13. Alford CA, Jr., Stagno S, Reynolds DW. Congenital toxoplas-mosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull New York Acad Med 1974; 50(2):160-81.
14. Guerina NG, Hsu HW, Meissner HC et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gon-dii infection. The New England Regional Toxoplasma Working Group. NEJM 1994; 330(26):1858-63.
15. Vela-Amieva M, Canedo-Solares I, Gutierrez-Castrellon P et al. Short report: neonatal screening pilot study of Toxoplasma gondii congenital infection in Mexico. Am J Trop Med Hyg 2005; 72(2):142-4.
16. Figueiró Filho E, Senefonte F, Lopes A et al. Frequência das infecções pelo HIV-1, rubéola, sífilis, toxoplasmose, citomegalovírus, herpes simples, hepatite B, hepatite C, doença de Chagas e HTLV I/II em gestantes do Estado de Mato Grosso do Sul. Rev Soc Bras Med Trop 2007; 40(2):181-7.
17. Figueiró-Filho E, Lopes A, Senefonte F et al. Toxoplasmose aguda: estudo da frequência, taxa de transmissão vertical e relação entre os testes diagnósticos materno-fetais em gestantes em estado da Região Centro-Oeste do Brasil. Rev Bras Ginecol Obstet 2005; 27(8):442-9.
18. Porto A, Amorim M, Coelho I, Santos L. Serologic profile of toxoplasmosis in pregnant women attended at a teaching-hospital in Recife. Rev Assoc Med Bras 2008; 54(3):242-8.
19. Rosso F, Les JT, Agudelo A et al. Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America. Am J Trop Med Hyg 2008; 78(3):504-8.
20. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982; 2(8302):781-4.
21. CDC. Achievements in Public Health: Elimination of Rubella and Congenital Rubella Syndrome- United States, 1969-2004. JAMA 2005; 293:2084-6.
22. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Re-comm Rep 2001; 50(RR-12):1-23.
23. Elimination of rubella and congenital rubella syndrome -United States, 1969-2004. MMWR 2005; 54(11):279-82.
24. Lanzieri TM, Segatto TC, Siqueira MM et al. Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001. Ped Infec Dis J 2003; 22(4):323-9.
25. Reiche EM, Morimoto HK, Farias GN et al. Prevalence of American trypanosomiasis, syphilis, toxoplasmosis, rubella, hepatitis B, hepatitis C, human immunodeficiency virus infection, assayed through serological tests among pregnant patients, from 1996 to 1998, at the Regional University Hospital Norte do Parana. Rev Soc Bras Med Trop 2000; 33(6):519-27.